rs148461790
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_145725.3(TRAF3):c.962G>A(p.Arg321Gln) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000696 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145725.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- TRAF3 haploinsufficiencyInheritance: AD Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152184Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000382 AC: 96AN: 251462 AF XY: 0.000412 show subpopulations
GnomAD4 exome AF: 0.000722 AC: 1055AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.000688 AC XY: 500AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000446 AC: 68AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 3 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 321 of the TRAF3 protein (p.Arg321Gln). This variant is present in population databases (rs148461790, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with TRAF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 569056). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
TRAF3-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at